Response to correspondence on "clinical seizures in neonatal hypoxic-ischemic encephalopathy have no independent impact on neurodevelopmental outcome: Secondary analyses of data from the neonatal research network hypothermia trial"

Journal of Child Neurology

Volumn 26, Issue 4, 2011, Pages 533-534

  Kwon, Jennifer M ^a   Guillet, Ronnie ^a   Shankaran, Seetha ^b   McDonald, Scott A ^c   Das, Abhik ^c  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

BRAIN DISEASE; BRAIN ELECTROPHYSIOLOGY; CHILDHOOD DISEASE; DISEASE SEVERITY; HUMAN; INDUCED HYPOTHERMIA; LETTER; MEDICAL RESEARCH; NEONATAL HYPOXIC ISCHEMIC ENCEPHALOPATHY; NERVE CELL DIFFERENTIATION; PRIORITY JOURNAL; SEIZURE; TREATMENT OUTCOME;

EID: 79954584832     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073811399804     Document Type: Letter

References (3)

1. Glass HC, Ferriero DM, Miller SP Correspondence on "Clinical Seizures in Neonatal Hypoxic-Ischemic Encephalopathy Have No Independent Impact on Neurodevelopmental Outcome: Secondary Analyses of Data From the Neonatal Research Network Hypothermia Trial." J Child Neurol. 2011 ; 26 (4). 532.
2. Kwon JM, Guillet RG, Shankaran S., et al. Clinical seizures in neonatal hypoxic-ischemic encephalopathy have no independent impact on neurodevelopmental outcome: secondary analyses of data from the Neonatal Research Network Hypothermia Trial. J Child Neurol. 2011 ; 26 (3). 322-328.
3. Ikonomidou C., Turski L. Antiepileptic drugs and brain development. Epilepsy Res. 2010 ; 88: 11-22.